Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Celebrity Attorney Mychal Wilson Comments On The $30M CDI Settlement with Bristol-Myers Squibb


News provided by

The Law Office of Mychal Wilson

14 Dec, 2016, 18:56 GMT

Share this article

Share toX

Share this article

Share toX

LOS ANGELES, Dec. 14, 2016 /PRNewswire/ -- Mychal Wilson, Esq., a former actor/producer and top big pharma cardiovascular/diabetes pharmaceutical sales representative announces that he was successful again for blowing the whistle against his former employer and pharmaceutical giant Bristol-Myers Squibb ("BMS") in the groundbreaking California health insurance fraud case in the amount of $30M.

This image opens in the lightbox
Celebrity Whistleblower Attorney Mychal Wilson (PRNewsFoto/The Law Office of Mychal Wilson)

"This $30M settlement under the California Insurance Code 1871.7 is another landmark whistleblower case that exposes conduct employed by a leading pharmaceutical company. After reporting fraud and subsequently terminated in 2004, then filing suit under the False Claims Act against BMS in 2006 which settled for $515M with the DOJ, this David versus Goliath battle between Mychal Wilson and BMS began under seal in March 2007. After being vetted and deposed by the state of California and defendant BMS, I feel honored to be rewarded for this groundbreaking legal victory," says Wilson.

Mychal Wilson states, "In my opinion, receiving kickbacks such as tickets and box suites for sporting events (i.e.-LA Lakers, LA Kings, and LA Dodgers), expensive restaurant meals and drinks, liquor, resort hotel trips, Swedish massages, concert tickets, golf outings, BMS employee and physician family basketball camps with LA Lakers, monetary incentives given to doctors responsible for prescription drug decisions on formularies, and pulling and flagging patient charts for drug therapy (which included the disadvantaged poor to Hollywood celebrities at Cedars-Sinai Medical Center) places patients in harms way, violates their privacy, and drives up the costs of healthcare."

"From a frontline insiders perspective who was managed and directed to sell billion dollar drugs such as Plavix, Pravachol, and Glucophage coupled with inducements, patients may want to seek a second or even a third opinion before committing to any drug therapy and/or invasive surgery," claims Wilson.

Mychal Wilson states, "I would like to thank and congratulate my courageous and perseverant former co-employees Eve and Lucius Allen (former college and NBA champion) for participating in this case and bringing justice on behalf of the State of California. We owe the Allens an enormous amount of gratitude and respect."

"Additionally, I would like to thank our great legal team WatersKrausPaul for its representation and groundbreaking legal work including attorneys Charles Siegel, Loren Jacobson, Mike Armitage, Louisa Kirakosian, Gary Paul and Michael Gurien, their office staff, the California Department of Insurance Department's (Commissioner Dave Jones, attorneys John Finston, Michael Levy, Tony Celaya, and Richard Krenz), former Attorney General Kamala Harris, Brooks Cutter and JR Parker of Cutter Law, PC, Alastair Findeis of Milberg, LLP, certified fraud examiner Andy Prough, our expert physicians, and healthcare industry informants for the great collaboration," says Wilson.

Wilson declares, "In today's world, these improper business arrangements have become the cost of doing business. These types of improper business arrangements may also create a false demand which has adversely increased today's drug premiums and drug pricing. Accordingly, improper business arrangements in the practice of medicine need to immediately cease and desist. Hopefully, in fulfilling one of his campaign promises, President-Elect Donald Trump and his new administration will take action against this type of government waste and abuse."

The lawsuit is captioned The People of the State of California ex rel. Michael Wilson, Lucius Allen, and Eve Allen, Relators vs. Bristol-Myers Squibb Inc., et al., Case Number BC 367873. The claims settled by this agreement are allegations only, and there has been no determination of liability.

CDI Press Release: Whistleblower lawsuit results in $30 million settlement with Bristol-Myers Squibb

About Mychal Wilson

Mychal Wilson is a whistleblower and entertainment law attorney. Mychal has been a member of the SAG-AFTRA ("Screen Actors Guild") since 1993 and is a media personality who regularly serves as a legal analyst on numerous media outlets such as BBC, OANN, RT and 790 KABC Radio Dr. Drew Midday Live with Mike Catherwood. Mychal Wilson's authored big pharma memoir "Pharma Chronicles: Drugs, Money and Sex" is scheduled to be released in 2017.

As a relator and Qui Tam attorney, Mychal Wilson has currently assisted state and federal governments in the recovery of over $580M in American taxpayers dollars. Currently, Mychal Wilson serves as counsel on several sealed and unsealed cases such as the False Claims Act misbranding spinal device case U.S. ex rel. Dan Abrams Company, LLC v. Medtronic, Case No. 2:15-cv-01212 (C.D. Cal.) and the intervened Texas Medicaid Fraud Prevention Act drug pricing case, State of Texas v. Lupin, Case No. D-1-GN-16-005758 (TX).

Mychal Wilson, Esq. is a member of the State Bar of California and admitted to practice law in the Eastern, Northern, Central and Southern United States District Courts of California, and the Supreme Court of the United States (SCOTUS).

Twitter: @mychalwilsonesq
www.mychalwilsonesq.com

Related Links

http://www.mychalwilsonesq.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.